Investing.com -- U.S. futures traded in a mixed fashion Thursday, as investors digested a deluge of corporate earnings, with the tech sector in particular focus.
Here are some of the biggest premarket U.S. stock movers today:
Tesla (NASDAQ: TSLA ) stock fell 3.6% after CEO Elon Musk revealed plans to continue price cuts, squeezing future margins, which outweighed the EV manufacturer comfortably beating second-quarter profit forecasts.
IBM (NYSE: IBM ) stock fell 0.9% after the tech giant’s second-quarter revenue fell short of expectations, bogged down by a decline in sales of its mainframe computers as businesses cut tech spending.
Johnson & Johnson (NYSE: JNJ ) stock rose 1.4% after the pharmaceutical company beat second-quarter earnings expectations and lifted its 2023 profit forecast as it builds out its drug and medical devices pipeline.
AB InBev ADRs (NYSE: BUD ) rose 0.6% after Morgan Stanley upgraded its stance on the brewer to ‘overweight’ from ‘neutral’, saying it is now attractively valued after the Bud Light controversy.
Taiwan Semiconductor Manufacturing (NYSE: TSM ) stock fell 3.5% after the Taiwanese chipmaker forecast a drop of around 10% in 2023 sales and flagged investment spending at the low end of estimates.
American Airlines (NASDAQ: AAL ) stock fell 1.3% despite the carrier raising its annual forecast for adjusted profit despite fears of a looming economic slowdown.
Philip Morris (NYSE: PM ) stock rose 0.1% after the tobacco giant impressed with its quarterly profit, boosted by a let-up in soaring tobacco and labor costs and buoyant demand for its Zyn and IQOS products.
Blackstone (NYSE: BX ) stock fell 3.2% after the asset manager said its second-quarter distributable earnings slumped nearly 40%, owing to a sharp drop in asset sales.
DR Horton (NYSE: DHI ) stock rose 3.8% after the home builder raised its forecast for full-year revenue, benefiting from strong demand and easing shortages of labor and construction supplies.
Abbott Laboratories (NYSE: ABT ) stock rose 0.7% after the medical devices manufacturer beat expectations for second-quarter profit, due to recovery in surgical procedure volumes and demand for its diabetes care devices.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.